SCHEMBL19009458

SCHEMBL19009458

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc(-c4cccc5ccccc45)cc(-c4cccc5ccccc45)c3)n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.56
ALDH1A1 P00352 5/20 0.56
HPGD P15428 5/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
KDM4E B2RXH2 4/20 0.56
MAPK1 P28482 2/20 0.56
HSD17B10 Q99714 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
TSHR P16473 2/20 0.56
ATM Q13315 2/20 0.56
TP53 P04637 1/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
TNF P01375 1/20 0.47
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18878248 0.96 MAPT (0.53) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL17932316 0.96 MAPT (0.53) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL18878247 0.96 MAPT (0.53) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL18327634 0.95 MAPT (0.51) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL17932355 0.95 MAPT (0.51) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL17932420 0.93 ALDH1A1 (0.50) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL17343297 0.93 MAPT (0.53) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL24837266 0.93 MAPT (0.53) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL18270310 0.93 MAPT (0.53) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL18270339 0.93 MAPT (0.53) MAPTALDH1A1HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225006-A2 ORGANIC LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2023-08-09 EP disclosed
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20200152902-A1 ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-05-14 US disclosed
EP-3651224-A1 ORGANIC ELECTROLUMINESCENCE DEVICE Samsung Display Co., Ltd. (KR) 2020-05-13 EP disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 MAPT 735/4885ALDH1A1 450/4885HPGD 2811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.